Logo

ABI Sues Stratagene in Europe for Allegedly Infringing qPCR Patent

May 30, 2007
NEW YORK (GenomeWeb News) — Applied Biosystems' parent company has sued Stratagene in the Netherlands and France for allegedly infringing an ABI patent, Stratagene said in a filing with the US Securities and Exchange Commission yesterday.
 
According to the filing, on May 23 Stratagene received a writ of summons filed by Applera in the District of The Hague in the Netherlands alleging that Stratagene's Mx3000P, Mx3005P, Mx4000P, and "certain related reagents" infringe ABI’s EU patent No. 0 872 562 B1.
 
Stratagene said it must appear at a preliminary court hearing on July 4 in the Netherlands, and that the company appoint an attorney from the Paris Bar by Aug. 9.
 
Applera wants the courts to bar Stratagene from selling these products in the Netherlands, France, and "certain other European nations."
 
Stratagene said that Applera's claims are "without merit" and that it intends to "vigorously defend these actions.”

Breaking News
The Scan

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.

Sequencing Study Leads to Vaccine Target in Bacteria Behind Neonatal Meningitis

Researchers eBioMedicine track down potential vaccine targets with transposon sequencing on mutant bacteria causing neonatal meningitis in mouse models of the disease.

Multiple Myeloma Progression Influenced by Immune Microenvironment Expression

Researchers in NPJ Genomic Medicine compare RNA sequencing profiles of 102,207 individual cells in bone marrow samples from 18 individuals with rapid or non-progressing multiple myeloma.

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.